Ruzurgi (amifampridine)

pCPA File Number: 22140
Negotiation Status:
Concluded with an LOI
Indication(s):
Lambert-Eaton Myasthenic Syndrome (LEMS)
Sponsor/Manufacturer:
Médunik Canada Inc.
CDA-AMC Project Number:
SR0660-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: